Photo by nci from unsplash
5595Background: Immune checkpoint inhibitors have shown promising activity in multiple tumor types. However, there are no approved IO for GYN. Methods: We identified GYN pts treated with IO from 20... Click to show full abstract
5595Background: Immune checkpoint inhibitors have shown promising activity in multiple tumor types. However, there are no approved IO for GYN. Methods: We identified GYN pts treated with IO from 20...
Keywords:
gynecological malignancies;
pts gynecological;
outcomes patients;
immune profile;
profile outcomes;
patients pts
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!